Carolinas Wealth Consulting’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30
Closed -$607 237
2025
Q1
$607 Hold
30
﹤0.01% 951
2024
Q4
$609 Sell
30
-15
-33% -$325 ﹤0.01% 989
2024
Q3
$1.03K Buy
45
+15
+50% +$323 ﹤0.01% 923
2024
Q2
$588 Buy
30
+20
+200% +$382 ﹤0.01% 980
2024
Q1
$188 Sell
10
-990
-99% -$18K ﹤0.01% 1022
2023
Q4
$19.8K Hold
1,000
﹤0.01% 444
2023
Q3
$15.6K Sell
1,000
-18
-2% -$370 ﹤0.01% 462
2023
Q2
$20.5K Hold
1,018
﹤0.01% 475
2023
Q1
$22.4K Hold
1,018
﹤0.01% 476
2022
Q4
$25.5K Sell
1,018
-77
-7% -$1.87K 0.01% 449
2022
Q3
$25K Hold
1,095
0.01% 411
2022
Q2
$28K Hold
1,095
0.01% 404
2022
Q1
$38K Hold
1,095
0.01% 389
2021
Q4
$40K Hold
1,095
0.01% 393
2021
Q3
$37K Hold
1,095
0.01% 385
2021
Q2
$36K Hold
1,095
0.01% 404
2021
Q1
$35K Hold
1,095
0.01% 422
2020
Q4
$33K Sell
1,095
-132
-11% -$3.84K 0.01% 401
2020
Q3
$33K Buy
1,227
+109
+10% +$2.99K 0.01% 340
2020
Q2
$31K Buy
+1,118
New +$28.5K 0.01% 249

Other funds holding DOC

Carolinas Wealth Consulting's DOC Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Healthpeak Properties (DOC) in Q2 2025, closing a stake of 30 shares — an estimated $607 sold.

Carolinas Wealth Consulting first reported a position in DOC in Q2 2020 and held it in 20 quarters. The position peaked at $40K in Q4 2021. 733 funds tracked by Wall St. Rank hold DOC as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Healthpeak Properties position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 30 Healthpeak Properties shares in Q2 2025, an estimated $607.
  • Carolinas Wealth Consulting first reported a position in Healthpeak Properties in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Healthpeak Properties position peaked at $40K in Q4 2021.
  • 733 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.